(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EKTERLY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

EKTERLY

ST13

US500000097832368

Class

5

Filing

97832368

Registration

7358603

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

06/11/2026

Trademark type

Word

Nice classes

5

Filing date

03/10/2023

Registration date

04/16/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/16/2024

Last transaction

06/11/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

13

Owner location

CAMANA BAY, US

Examiner

JOINER, KATINA JACKSON

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

D. L. (pessoa física)
Kalvista Pharmaceuticals Limited

Representatives

Stacy L. Wu Cast Legal Studio PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders; pharmaceutical preparations containing sebetralstat for the treatment of angioedemahereditary angioedemabradykinin mediated inflammatory disordersplasma kallikrein or factor XIIa mediated diseases or disordersdiseases and disorders mediated by the contact activation system

Publications

History of USPTO decisions and trademark events.

24 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/10/2026

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/06/2026

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

10/09/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/09/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/09/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/09/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/09/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/09/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/16/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/16/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/30/2024

PUBO

PUBLISHED FOR OPPOSITION

01/30/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/10/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/27/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/26/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/26/2023

ALIE

ASSIGNED TO LIE

12/26/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/31/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/12/2023

GNRT

NON-FINAL ACTION E-MAILED

05/12/2023

CNRT

NON-FINAL ACTION WRITTEN

05/12/2023

DOCK

ASSIGNED TO EXAMINER

05/05/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/30/2023

NWAP

NEW APPLICATION ENTERED

03/14/2023

Continuous trademark protection

Get notified about every new filing that threatens EKTERLY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.